NASDAQ:GRPH

Graphite Bio News Headlines

$8.41

-0.61 (-6.76%)

(As of 12/1/2021 12:00 AM ET)

Add

Compare

Today's Range: $8.35
▼
$9.33
50-Day Range: $8.41
▼
$20.15
52-Week Range: $8.11
▼
$34.00

Volume: 169,637 shs
Average Volume: 331,424 shs
Market Capitalization: $488.44 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Media Mentions By Week

Graphite Bio Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GRPH
News Sentiment
▼
0.67

0.29
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GRPH Articles
This Week
▼
1

1
▲
GRPH Articles
Average Week

Get Graphite Bio News Delivered to You Automatically

Graphite Bio (NASDAQ:GRPH) News Headlines Today

Source

Source	Headline
	Graphite Bio (NASDAQ:GRPH) Stock Price Down 7.1% americanbankingnews.com - November 29 at 4:08 PM
	Graphite Bio, Inc. (NASDAQ:GRPH) Major Shareholder Biocapital L.P. Samsara Purchases 201,685 Shares americanbankingnews.com - November 24 at 2:10 PM
	Graphite Bio (NASDAQ:GRPH) Shares Up 6.9% americanbankingnews.com - November 24 at 1:38 PM
	Graphite Bio (NASDAQ:GRPH) Hits New 52-Week Low at $10.48 americanbankingnews.com - November 22 at 11:00 AM
	Graphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease finance.yahoo.com - November 17 at 10:05 AM
	Graphite Bio (NASDAQ:GRPH) Sets New 12-Month Low at $11.61 americanbankingnews.com - November 15 at 12:43 PM
	Graphite Bio, Inc. Expected to Earn FY2021 Earnings of ($2.34) Per Share (NASDAQ:GRPH) americanbankingnews.com - November 15 at 1:58 AM
	Graphite Bio (NASDAQ:GRPH) Rating Reiterated by SVB Leerink americanbankingnews.com - November 14 at 11:50 AM
	Graphite Bio (NASDAQ:GRPH) Posts Earnings Results, Hits Expectations americanbankingnews.com - November 11 at 5:05 PM
	Graphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results finance.yahoo.com - November 10 at 7:51 PM
	Graphite Bio (NASDAQ:GRPH) Stock Price Up 10.1% americanbankingnews.com - November 8 at 2:48 PM
	Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit finance.yahoo.com - October 21 at 10:44 AM

	10% Owner Of Graphite Bio Makes $670K Buy finance.yahoo.com - October 18 at 5:26 PM
	Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention finance.yahoo.com - October 12 at 2:08 PM
	Graphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National Convention finance.yahoo.com - October 5 at 8:33 AM
	Graphite Bio (NASDAQ:GRPH) Is In A Good Position To Deliver On Growth Plans nasdaq.com - September 25 at 7:25 PM
	We Think Graphite Bio (NASDAQ:GRPH) Can Afford To Drive Business Growth finance.yahoo.com - September 25 at 2:24 PM
	Graphite Bio Announces Participation in Upcoming September Investor Conferences finance.yahoo.com - August 30 at 8:21 AM
	New 52-Week Low Could Prompt More Insider Buying At GRPH nasdaq.com - August 20 at 4:06 PM
	Graphite Bio Reports Recent Business Progress and Second Quarter 2021 Financial Results finance.yahoo.com - August 12 at 4:29 PM
	Graphite Bio, Inc. (GRPH) ca.finance.yahoo.com - July 21 at 7:41 PM
	Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish markets.businessinsider.com - July 20 at 6:37 PM
	Graphite Bio, Inc. Common Stock (GRPH) nasdaq.com - July 16 at 11:43 PM
	Graphite Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares finance.yahoo.com - June 30 at 8:46 PM
	Graphite Bio Announces Pricing of Upsized Initial Public Offering finance.yahoo.com - June 28 at 8:28 AM

Get Graphite Bio News Delivered to You Automatically

This page was last updated on 12/2/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources